CRISPR Therapeutics
CRSP
#3225
Rank
$4.85 B
Marketcap
$50.04
Share price
-0.06%
Change (1 day)
-8.32%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement